Evidence indicates NSCLC patients overexpress RXRα and RARγ; conversely, RARβ suppression exists, suggesting an imbalance in the receptors’ expression that could play an essential role in cancer genesis (12). Here, RARB is linked to non-small cell lung carcinoma.